Objective evaluation for treat to target in Crohn’s disease Kento TakenakaYoshio KitazumeKazuo Ohtsuka Review Open access 04 March 2020 Pages: 579 - 587
Emerging therapies in primary sclerosing cholangitis: pathophysiological basis and clinical opportunities Mette VesterhusTom Hemming Karlsen Review Open access 28 March 2020 Pages: 588 - 614
A nationwide, multi-center, retrospective study of symptomatic small bowel stricture in patients with Crohn’s disease Shigeki BambaRyosuke SakemiToshifumi Hibi Original Article—Alimentary Tract 27 January 2020 Pages: 615 - 626
Ramucirumab after prior sorafenib in patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein: Japanese subgroup analysis of the REACH-2 trial Masatoshi KudoTakuji OkusakaAndrew X. Zhu Original Article—Liver, Pancreas, and Biliary Tract Open access 27 February 2020 Pages: 627 - 639
JNJ-4178 (adafosbuvir, odalasvir, and simeprevir) in Japanese patients with chronic hepatitis C virus genotype 1 or 2 infection with or without compensated cirrhosis: the Phase IIa OMEGA-3 study Tetsuo TakeharaKazuaki ChayamaNorio Hayashi Original Article—Liver, Pancreas, and Biliary Tract Open access 17 February 2020 Pages: 640 - 652
Real world data of liver injury induced by immune checkpoint inhibitors in Japanese patients with advanced malignancies Kazuyuki MizunoTakanori ItoMitsuhiro Fujishiro Original Article—Liver, Pancreas, and Biliary Tract 02 March 2020 Pages: 653 - 661
Can portal hypertension and hepatic decompensation be predicted? Kosuke KajiHitoshi Yoshiji Editorial 21 January 2020 Pages: 662 - 663
Paradox of age-specific incidence rates of second primary cancer in individuals with esophageal cancer Tomonori Yano Editorial 13 April 2020 Pages: 664 - 665
Correction to: Genomic landscape of epithelium with low-grade atypia on gastric cancer after Helicobacter pylori eradication therapy Kazuhiko MasudaYuji UrabeKazuaki Chayama Correction 19 April 2020 Pages: 666 - 666